Pathobiology of Human Germ Cell Neoplasia

por Ledermann, J.A.
Publicado 1992

Phase I Cancer Clinical Trials

por Ledermann, J A
Publicado 2007

Ovarian cancer – American cancer society atlas of clinical oncology

por Ledermann, J A
Publicado 2004

Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.

por Ledermann, J. A., Begent, R. H., Bagshawe, K. D.
Publicado 1988

Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal...

por Leonard, P, Seymour, M T, James, R, Hochhauser, D, Ledermann, J A
Publicado 2002

A Survey of Non-Embolic Stroke in Adults under 50 Years of Age

por Ledermann, J. A., Murphy, P. J., Hamilton, M., Hoffbrand, B. I.
Publicado 1985

Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy

por Wynne, P, Newton, C, Ledermann, J A, Olaitan, A, Mould, T A, Hartley, J A
Publicado 2007

Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer.

por Ledermann, J. A., Marston, N. J., Stahel, R. A., Waibel, R., Buscombe, J. R., Ell, P. J.
Publicado 1993

Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.

por Ornadel, D., Ledermann, J. A., Eagle, K., Pedley, R. B., Boxer, G., Ward, S. E., Olabiran, Y., Bomanji, J.
Publicado 1998

Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer

por Raja, F A, Griffin, C L, Qian, W, Hirte, H, Parmar, M K, Swart, A M, Ledermann, J A
Publicado 2011

The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

por Olabiran, Y., Ledermann, J. A., Marston, N. J., Boxer, G. M., Hicks, R., Souhami, R. L., Spiro, S. G., Stahel, R. A.
Publicado 1994

A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases.

por Howell, J. D., McArdle, C. S., Kerr, D. J., Buckles, J., Ledermann, J. A., Taylor, I., Gallagher, H. J., Budden, J.
Publicado 1997

Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.

por Ledermann, J. A., Begent, R. H., Bagshawe, K. D., Riggs, S. J., Searle, F., Glaser, M. G., Green, A. J., Dale, R. G.
Publicado 1988

Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.

por Boxer, G. M., Begent, R. H., Kelly, A. M., Southall, P. J., Blair, S. B., Theodorou, N. A., Dawson, P. M., Ledermann, J. A.
Publicado 1992

Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

por Begent, R. H., Ledermann, J. A., Green, A. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Keep, P. A., Adam, T., Dale, R. G., Glaser, M. G.
Publicado 1989

A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer

por McCormack, M, Kadalayil, L, Hackshaw, A, Hall-Craggs, M A, Symonds, R P, Warwick, V, Simonds, H, Fernando, I, Hammond, M, James, L, Feeney, A, Ledermann, J A
Publicado 2013

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F...

por Lane, D. M., Eagle, K. F., Begent, R. H., Hope-Stone, L. D., Green, A. J., Casey, J. L., Keep, P. A., Kelly, A. M., Ledermann, J. A., Glaser, M. G.
Publicado 1994

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

por Ledermann, J.A., Embleton-Thirsk, A.C., Perren, T.J., Jayson, G.C., Rustin, G.J.S., Kaye, S.B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A.M., Kaplan, R.S., Parmar, M.K.B.
Publicado 2021

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-cont...

por Ledermann, J.A., Zurawski, B., Raspagliesi, F., De Giorgi, U., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R.L., Markowska, J., Cebotaru, C., Casado Herraez, A., Colombo, N., Kutarska, E., Hall, M., Jacobs, A., Ahrens-Fath, I., Baumeister, H., Zurlo, A., Sehouli, J.
Publicado 2021

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

por Adams, M., A'Hern, R. P., Calvert, A. H., Carmichael, J., Clark, P. I., Coleman, R. E., Earl, H. M., Gallagher, C. J., Ganesan, T. S., Gore, M. E., Graham, J. D., Harper, P. G., Jayson, G. C., Kaye, S. B., Ledermann, J. A., Osborne, R. J., Perren, T. J., Poole, C. J., Radford, J. A., Rustin, G. J., Slevin, M. L., Smyth, J. F., Thomas, H., Wilkinson, P. M.
Publicado 1998